Open AccessTHE UNEXPLORED ROLES OF PROBIOTIC BACTERIA: IN VITRO ANTI-INFLAMMATORY AND ANTHELMINTIC ACTIVITY OF ENTEROCOCCUS FAECIUM BM10 KY788342 AND LACTOBACILLUS CASEI GM10 KY794586
Author(s) -
Neha Jain,
Archana Mehta
Publication year - 2017
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2017.v10i9.19413
Subject(s) - enterococcus faecium , lactobacillus casei , anthelmintic , probiotic , microbiology and biotechnology , in vitro , biology , enterococcus , lactobacillus , chemistry , pharmacology , bacteria , antibiotics , biochemistry , ecology , genetics
Objective: The aim of the present study was to evaluate the in vitro anti-inflammation activity and anthelmintic potential of two novel isolated probiotic strains through Enterococcus faecium BM10 KY788342 and Lactobacillus casei GM10 KY794586.Methods: In vitro anti-inflammatory activity was evaluated using protein denaturation inhibition method. Pheretima posthuma was used as a suitable in vitro model, and time of paralysis and death were used as parameters to evaluate anthelmintic potential of probiotic strains.Results: Lyophilized solutions of L. casei GM10 showed significant protein denaturation inhibition (56.20±0.86%) followed by E. faecium BM10 (52.28±0.31%) comparable to diclofenac (93.62±1.39%) at the maximum concentration of 250 μg/ml. Intracellular cell-free extract of E. faecium BM10 showed a strong anthelmintic (vermicidal) activity (6±0.23 minutes), followed by L. casei GM10 (9±0.05 minutes) comparable to piperazine citrate (20±0.422 minutes) and albendazole (24±0.43 minutes) at the maximum concentration of 100 mg/ml.Conclusion: Results of the present study concluded that both tested lactic acid bacteria strains exhibited significant in vitro anti-inflammatory activity and can be used as potent and safe anthelmintic agent.